Recognized by Young Indians (Yi) – CII as an Emergency Medicine Supplier During COVID-19

Young Indians (Yi), an initiative of the Confederation of Indian Industry (CII), recognized ShivShivam Pharma Private Limited as an Emergency Medicine Supplier during the COVID-19 pandemic.

Young Indians (Yi) – CII Recognition

The recognition highlighted ShivShivam Pharma’s role in supporting the availability of essential medicines during the pandemic. The listing included medicines such as Tocilizumab, Remdesivir, and Favipiravir, supplied against valid medical prescriptions.

Furthermore, our team worked to support hospitals and healthcare professionals during a period of high demand. We focused on maintaining reliable supply and timely coordination.

Supporting Medicine Availability

During the pandemic, we focused on the availability of essential medicines. In addition, our team worked closely with healthcare partners to support timely requirements.

We also maintained a strong focus on responsible pharmaceutical distribution. Therefore, our efforts supported hospitals and healthcare professionals during a challenging period.

A Proud Recognition for ShivShivam Pharma

The Young Indians (Yi) – CII recognition represents an important milestone for ShivShivam Pharma.

Moreover, the recognition reflects the trust placed in our company during a national health emergency. It also highlights our commitment to reliable pharmaceutical distribution.

We remain focused on quality, responsibility, and customer service. Furthermore, we continue to support healthcare partners and work toward improving access to essential medicines across India.